Quanterix (QTRX) Free Cash Flow (QoQ) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Quanterix | 165.84 Mn | 66.57 Mn | 15.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.36% |
| Dec 31, 2025 | 52.27% |
| Sep 30, 2025 | -513.26% |
| Jun 30, 2025 | 57.53% |
| Mar 31, 2025 | -218.82% |
| Dec 31, 2024 | -7.37% |
| Sep 30, 2024 | 32.46% |
| Jun 30, 2024 | 68.31% |
| Mar 31, 2024 | -106.02% |
| Dec 31, 2023 | -243.71% |
| Sep 30, 2023 | -1,352.79% |
| Jun 30, 2023 | 102.34% |
| Mar 31, 2023 | -272.60% |
| Dec 31, 2022 | 131.26% |
| Sep 30, 2022 | -42.52% |
| Jun 30, 2022 | 43.84% |
| Mar 31, 2022 | -2,588.15% |
| Dec 31, 2021 | 105.27% |
| Sep 30, 2021 | -3.48% |
| Jun 30, 2021 | -20.05% |
| Mar 31, 2021 | -1,409.43% |
| Dec 31, 2020 | 116.86% |
| Sep 30, 2020 | 26.08% |
| Jun 30, 2020 | 34.64% |
| Mar 31, 2020 | -185.37% |
| Dec 31, 2019 | -588.35% |
| Sep 30, 2019 | 108.37% |
| Jun 30, 2019 | -0.99% |
| Mar 31, 2019 | -65.99% |
| Dec 31, 2018 | 15.25% |
| Sep 30, 2018 | -129.54% |
| Jun 30, 2018 | 66.79% |
| Mar 31, 2018 | -121.66% |
| Dec 31, 2017 | 37.74% |
| Sep 30, 2017 | -11.80% |
| Jun 30, 2017 | -67.31% |